Effect of interleukin 17 on proteoglycan degradation in murine knee joints

Annals of the Rheumatic Diseases

Volumn 59, Issue 7, 2000, Pages 529-532

  Dudler, Jean ^a   Renggli Zulliger, Nicole ^a   Busso, Nathalie ^a   Lotz, Martin ^b   So, Alexander ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; PERTECHNETIC ACID TC 99M; PROTEOGLYCAN;

ANIMAL EXPERIMENT; ARTICLE; CARTILAGE DEGENERATION; CONTROLLED STUDY; DRUG EFFECT; HISTOPATHOLOGY; INJECTION; KNEE ARTHRITIS; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEOGLYCAN SYNTHESIS; SYNOVIOCYTE;

ANIMALS; ARTHRITIS; CARTILAGE; FEMALE; INTERLEUKIN-17; KNEE JOINT; MALE; MICE; MICE, INBRED C57BL; PROTEOGLYCANS;

EID: 0033938870     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.59.7.529     Document Type: Article

References (22)

1. 1 Rouvier E, Luciani MF, Mattei MG, Denizot F, Golstein P. CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J Immunol 1993;150:5445-56.
2. 2 Yao Z, Fanslow WC, Seldin MF, Rousseau AM, Painter SL, Comeau MR, et al. Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 1995;3:811-21.
3. 3 Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Spriggs MK, et al. Human IL-17: a novel cytokine derived from T cells. J Immunol 1995;155:5483-6.
4. 4 Kennedy J, Rossi DL, Zurawski SM, Vega Jr F, Kastelein RA, Wagner JL, et al. Mouse IL-17: a cytokine preferentially expressed by alpha beta TCR + CD4-CD8-T cells. J Interferon Cytokine Res 1996;16:611-17.
5. 5 Yao Z, Spriggs MK, Derry JM, Strockbine L, Park LS, VandenBos T, et al. Molecular characterization of the human interleukin (IL)-17 receptor. Cytokine 1997;9:794 800.
6. 6 Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, et al. Human interleukin-17 - a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 1999;42:963-70.
7. 7 Miossec P, van den Berg W. Th1/Th2 cytokine balance in arthritis. Arthritis Rheum. 1997;40:2105-15.
8. 8 Dolhain RJ, van der Heiden AN, ter Haar NT, Breedveld FC, Miltenburg AM. Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis Rheum 1996;39: 1961-9.
9. 9 Aarvak T, Chabaud M, Miossec P, Natvig JB. IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells. J Immunol 1999;162:1246-51.
10. 10 Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C, et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines [see comments]. J Exp Med 1996;183:2593 603.
11. 11 Chabaud M, Fossiez F, Taupin JL, Miossec P. Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. J Immunol 1998;161: 409-14.
12. 12 Jovanovic DV, Di Battista JA, Martel-Pelletier J, Jolicoeur FC, He Y, Zhang M, et al. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol 1998;160: 3513-21.
13. 13 Attur MG, Patel RN, Abramson SB, Amin AR. Interleukin-17 up-regulation of nitric oxide production in human osteoarthritis cartilage. Arthritis Rheum 1997;40: 1050-3.
14. 14 Shalom-Barak T, Quach J, Lotz M. Interleukin-17-indueed gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB. J Biol Chem 1998;273:27467-73.
15. 15 Lens JW, van den Berg WB, van de Putte LB. Quantitation of arthritis by 99mTc-uptake measurements in the mouse knee-joint: correlation with histological joint inflammation scores. Agents Actions 1984;14:723-8.
16. 3H-acetate. Rheumatol Int 1986;6:273-81.
17. 17 van de Loo AA, van Beuningen HM, van Lent PL, van den Berg WB. Direct effect of murine rIL-1 on cartilage metabolism in vivo. Agents Actions 1989;26:153-5.
18. 18 van Beuningen HM, Arntz OJ, van den Berg WB. In vivo effects of interleukin-1 on articular cartilage. Prolongation of proteoglycan metabolic disturbances in old mice. Arthritis Rheum 1991;34:606-15.
19. 19 van de Loo AA, van den Berg WB. Effects of murine recombinant interleukin 1 on synovial joints in mice: measurement of patellar cartilage metabolism and joint inflammation. Ann Rheum Dis 1990;49:238-45.
20. 20 van den Berg WB, van de Loo FA, Zwarts WA, Otterness IG. Effects of murine recombinant interleukin 1 on intact homologous articular cartilage: a quantitative and autoradiographic study. Ann Rheum Dis 1988;47:855-63.
21. 21 Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 1999;103:1345-52.
22. 22 Van Bezooijen RL, Farih-Sips HC, Papapoulos SE, Lowik CW. Interleukin-17: a new bone acting cytokine in vitro. J Bone Miner Res 1999;14:1513-21.